Spontaneous resolution of lupus nephritis following withdrawal of etanercept

Annals of Clinical and Laboratory Science

Volumn 43, Issue 4, 2013, Pages 447-449

  Yahya, Taher M ^a   Dhanyamraju, Susmitha ^a   Harrington, Thomas M ^a   Prichard, Jeffrey W ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

Etanercept; Glomerulonephritis; Kidney biopsy; Lupus nephritis

Indexed keywords

COMPLEMENT; DOUBLE STRANDED DNA ANTIBODY; ETANERCEPT; AUTOANTIBODY; CREATINE; IMMUNOGLOBULIN G; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; FEMALE; GLOMERULUS; HEMATURIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; PRIORITY JOURNAL; PROTEINURIA; PSORIASIS; ANTAGONISTS AND INHIBITORS; BLOOD; BLOOD ANALYSIS; CHEMICALLY INDUCED; DRUG EFFECTS; ELECTRON MICROSCOPY; IMMUNOLOGY; KIDNEY; MIDDLE AGED; PATHOLOGY; ULTRASTRUCTURE; URINALYSIS;

AUTOANTIBODIES; BLOOD CHEMICAL ANALYSIS; CREATINE; FEMALE; HUMANS; IMMUNOGLOBULIN G; KIDNEY; LUPUS NEPHRITIS; MICROSCOPY, ELECTRON; MIDDLE AGED; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA; URINALYSIS;

EID: 84889045472     PISSN: 00917370     EISSN: 15508080     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Brion PH, Mittal-Henkle A, Kalunian KC. Autoimmune skin rashes associated with etanercept for rheumatoid arthritis. Ann Intern Med. 1999 Oct 19;131(8):634.
2. Fusconi M, Vannini A, Dall'Aglio AC, Pappas G, Bianchi FB, Zauli D. Etanercept and infliximab induce the same serological autoimmune modifications in patients with rheumatoid arthritis. Rheumatol Int. 2007 Nov;28(1):47-9.
3. Wetter DA, Davis MD. Lupus-like syndrome attributable to anti-tumor necrosis factor alpha therapy in 14 patients during an 8-year period at mayo clinic. Mayo Clin Proc. 2009 Nov;84(11):979-84.
4. Ramos-Casals M, et al. Autoimmune diseases induced by TNF-targeted therapies-analysis of 233 cases. Medicine 2007;86:242-251
5. De Bandt M, Sibilia J, Le Loet X, Prouzeau S, Fautrel B, Marcelli C, et al. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: A French national survey. Arthritis Res Ther. 2005;7(3):R545-51.
6. Costa MF, Said NR, Zimmermann B. Drug-induced lupus due to anti-tumor necrosis factor alpha agents. Semin Arthritis Rheum. 2008 Jun;37(6):381-7.
7. Stokes MB, Foster K, Markowitz GS, Ebrahimi F, Hines W, Kaufman D, et al. Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis. Nephrol Dial Transplant. 2005 Jul;20(7):1400-6.
8. Doulton TW, Tucker B, Reardon J, Velasco N. Antineutrophil cytoplasmic antibody-associated necrotizing crescentic glomerulonephritis in a patient receiving treatment with etanercept for severe rheumatoid arthritis. Clin Nephrol2004;62:234-8.
9. Mor A, Bingham C,3rd, Barisoni L, Lydon E, Belmont HM. Proliferative lupus nephritis and leukocytoclastic vasculitis during treatment with etanercept. J Rheumatol. 2005 Apr;32(4):740-3.